Protective effect of oral lactobacilli in pathogenesis of chronic periodontitis

Journal of Physiology and Pharmacology

Volumn 62, Issue 6, 2011, Pages 685-689

  Szkaradkiewicz, A K ^a   Wyganowska Swiatkowska, M ^a   Karpinski, T M ^a   Zeidler, A ^a   Szkaradkiewicz, A ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Gingivitis; Hydrogen peroxide; Interleukin 17; Lactobacillus; Periodontitis; Tumour necrosis factor

Indexed keywords

HYDROGEN PEROXIDE; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; LACTOBACILLUS; MALE; PROTECTION; TH17 CELL;

ADMINISTRATION, ORAL; ADULT; CHRONIC PERIODONTITIS; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-17; LACTOBACILLUS; MALE; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856901601     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the 'red complex', a prototype polybacterial pathogenic consortium in periodontitis. Periodontology 2000 2005; 38: 72-122.
2. Ledder RG, Gilbert P, Huws SA, et al. Molecular analysis of the subgingival microbiota in health and disease. Appl Environ Microbiol 2007; 73: 516-523.
3. Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005; 32: 383-389.
4. Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009; 24: 1-6.
5. Santos VR, Ribeiro FV, Lima JA, Napimoga MH, Bastos MF, Duarte PM. Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects. J Clin Periodontol 2010; 37: 1049-1058.
6. Szkaradkiewicz AK, Tukiendorf B, Stopa J. Oral lactobacilli and periodontitis. Clin Microbiol Infect 2006; 12: 0371.
7. Szkaradkiewicz AK, Stopa J. Lactobacillus spp. of oral cavity microflora in chronic periodontitis. Pol J Environ Stud 2008; 17: 236-242.
8. Listgarten MA, Mao R, Robertson P. Periodontal probing and the relationship of the probe tip to periodontal tissues. J Periodontol 1976; 47: 511-513.
9. Benamghar L, Penaud J, Kaminsky P, Abt F, Martin J. Comparison of gingival index and sulcus bleeding index as indicators of periodontal status. Bull World Health Organ 1982; 60(1): 147-151.
10. Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005; 20: 354-361.
11. http://www.whocollab.od.mah.se [accessed on 25 November 2009] WHO Oral Health Country/Area Profile Programme. WHO Headquarters Geneva and WHO Collaborating Centre - Malmo University, Sweden.
12. Rabe LK, Hillier SL. Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol 2003; 41: 3260-3264.
13. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009; 2: 403-411.
14. Zenewicz LA, Flavell RA. IL-22 and inflammation: Leukin' through a glass onion. Eur J Immunol 2008; 38: 3265-3268.
15. Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009; 180: 720-730.
16. Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311.
17. Cho JS, Pietras EM, Garcia NC, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120: 1762-1773.
18. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 27: 2673-2682.
19. Duarte PM, da Rocha M, Sampaio E, et al. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol 2010; 81: 1056-1063.
20. Kirkham BW, Lassere MN, Edmonds JP, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006; 54: 1122-1131.
21. Oda T, Yoshie H, Yamazaki K. Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol 2003; 18: 30-36.
22. Kim KW, Cho ML, Park MK, et al. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7: R139-R148.
23. Inoue R, Otsuka M, Nishio A, Ushida K. Primary administration of Lactobacillus johnsonii NCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga mice. FEMS Immunol Med Microbiol 2007; 50: 67-76.
24. Vissers YM, Snel J, Zuurendonk PF, Kleerebezem M, Wichers HJ, Savelkoul HF. Lactobacillus strains differentially modulate cytokine production by Lactobacillus hPBMC from pollen-allergic patients. FEMS Immunol Med Microbiol 2011; 61: 28-40.
25. Gad M, Ravn P, Soborg DA, Lund-Jensen K, Ouwehand AC, Jensen SS. Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunol Med Microbiol 2011; 63: 93-107.
26. Konturek PC, Sliwowski Z, Koziel J, et al. Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress. J Physiol Pharmacol 2009; 60(Suppl 6): 41-48.
27. Cadieux PA, Burton JP, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009; 60(Suppl 6): 13-18.
28. Teanpaisan R, Piwat S, Dahlen G. Inhibitory effect of oral Lactobacillus against oral pathogens. Lett Appl Microbiol 2011; 53: 452-459.